Methicillin-resistant staphylococci as an epidemiological indication for gentamicin therapy.
D000284:Administration, Oral; D002353:Carrier State; D003718:Denmark; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005672:Fusidic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008034:Lincomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008712:Methicillin / Q000494:pharmacology*; D010403:Penicillin Resistance; D003668:Pressure Ulcer / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects*; D013530:Surgical Wound Infection / Q000188:drug therapy; D013548:Sweden
D005839:Gentamicins; D005672:Fusidic Acid; D008034:Lincomycin; D008712:Methicillin